Skip to main content

and
  1. No Access

    Article

    The clinical observation of combined chemotherapy of irinotecan and cisplatin in the treatment of relapsed advanced small cell lung cancer

    To evaluate the efficacy and safety of the irinotecan and cisplatin combination in relapsed advanced small cell lung cancer (SCLC).

    Zhonghai Ren, Chenghui Zhang, Ming Li in The Chinese-German Journal of Clinical Oncology (2008)

  2. No Access

    Article

    A preliminary study on K-ras, EGFR, and B-raf mutations of esophageal squamous cell carcinoma

    Molecular targeted drugs have been widely used in clinical application which has successfully prolonged some patients’ life. Meanwhile, molecular targeted drug therapy for esophageal cancer are attracting more...

    Huili Ma, Yongfei Xue, Changsheng Li in The Chinese-German Journal of Clinical Onc… (2011)

  3. Article

    Open Access

    Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer

    The purpose of this study was to evaluate the safety and efficacy of low-dose-intensity bevacizumab and weekly irinotecan as salvage treatment for patients with platinum- and taxanes-resistant advanced epithe...

    Ying Liu, Zhonghai Ren, Shuning Xu, Hua Bai in Cancer Chemotherapy and Pharmacology (2015)